Please login to the form below

Not currently logged in
Email:
Password:

Lundbeck

This page shows the latest Lundbeck news and features for those working in and with pharma, biotech and healthcare.

Lundbeck signs $1.1bn deal for Prexton and Parkinson’s drug

Lundbeck signs $1.1bn deal for Prexton and Parkinson’s drug

Lundbeck signs $1.1bn deal for Prexton and Parkinson’ s drug. Foliglurax is currently in phase II testing for LID, muscle stiffness and ‘freezing’. ... Lundbeck says data from the phase II trial is due early next year, while a second trial is also

Latest news

More from news
Approximately 55 fully matching, plus 124 partially matching documents found.

Latest Intelligence

  • Digital disruption Digital disruption

    R&D, this time within psychiatric and neurological treatments, was in the mind of Lundbeck executives when they signed a drug research deal with IBM Watson Health in February. ... Starting with projects in schizophrenia and Parkinson’s disease,

  • Communiqué Awards 2014 Digital Publication Communiqué Awards 2014 Digital Publication

    See which healthcare communications programmes made a real difference to health outcomes with the Communiqué Awards digital publication.

  • The Chinese diabetes challenge The Chinese diabetes challenge

    Last month's ChinaBio Partnering Forum in Suzhou, for example, was sponsored by (among others) AstraZeneca, Bayer, Bristol-Myers Squibb, Johnson &Johnson, Lilly, Lundbeck, Novo Nordisk and Roche.

  • Deal Watch table for June 2014 Deal Watch table for June 2014

    825. Chelsea Therapeutics/ Lundbeck. Company acquisition. Includes Northera (droxidopa) for neurogenic orthostatic hypotension (approved).

  • Deal Watch table for May 2014 Deal Watch table for May 2014

    1, 030. Chelsea / Lundbeck. Company acquisition. US company with treatments for rare neurologic diseases.

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 20 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics